Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial

BACKGROUND: Epidermal growth factor receptors contribute to breast cancer relapse during endocrine therapy. Substitution of aromatase inhibitors (AIs) may improve outcomes in HER-positive cancers. METHODS: Tissue microarrays were constructed. Quantitative analysis of HER1, HER2, and HER3 was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartlett, J M S, Brookes, C L, Piper, T, van de Velde, C J H, Stocken, D, Lyttle, N, Hasenburg, A, Quintayo, M A, Kieback, D G, Putter, H, Markopoulos, C, Kranenbarg, E M-K, Mallon, E A, Dirix, L Y, Seynaeve, C, Rea, D W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817340/
https://www.ncbi.nlm.nih.gov/pubmed/24091623
http://dx.doi.org/10.1038/bjc.2013.609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817340/
https://www.ncbi.nlm.nih.gov/pubmed/24091623
http://dx.doi.org/10.1038/bjc.2013.609

Ejemplares similares